The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Oral paclitaxel, carboplatin, and dostarlimab (OPE/Cb/D) without and with trastuzumab in early-stage, high-risk breast cancer: Results from the neoadjuvant I-SPY 2 TRIAL.
 
Kay T Yeung
Research Funding - BioFluidica (Inst); Immunomedics/Gilead (Inst); Ionis Pharmaceuticals (I); Kaneka Corporation (I); Zymeworks (Inst)
 
Kevin Kalinsky
Employment - EQRx (I); GRAIL (I)
Stock and Other Ownership Interests - EQRx (I); GRAIL (I)
Consulting or Advisory Role - 4D Pharma; AstraZeneca; Daiichi Sankyo/Astra Zeneca; Genentech/Roche; immunomedics; Lilly; Menarini Silicon Biosystems; Merck; mersana; Myovant Sciences; Novartis; Oncosec; Prelude Therapeutics; Puma Biotechnology; Seagen; Takeda
Research Funding - Ascentage Pharma (Inst); AstraZeneca (Inst); Daichi Sankyo (Inst); Genentech/Roche (Inst); Lilly (Inst); Novartis (Inst); Seagen (Inst)
Other Relationship - Genentech; Immunomedics
 
Christina Yau
Patents, Royalties, Other Intellectual Property - U.S. Provisional Application No. 63/314,065 (Inst); U.S. Provisional Application No. 63/341,579 (Inst)
 
Amy Jo Chien
Honoraria - bioTheranostics; sanofi
Consulting or Advisory Role - Novartis; SeaGen
Research Funding - Amgen (Inst); Merck (Inst); Puma Biotechnology (Inst); Seagen (Inst)
 
Judy Caroline Boughey
Honoraria - PeerView; PER; UpToDate
Consulting or Advisory Role - CairnSurgical; SymBioSis (Inst)
Research Funding - Lilly (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending - METHODS AND MATERIALS FOR ASSESSING CHEMOTHERAPY RESPONSIVENESS AND TREATING CANCER (Inst)
 
Erica Michelle Stringer-Reasor
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Lilly; Merck; Merck; Novartis; OncoSec; Seagen
Research Funding - Susan G. Komen for the Cure; V Foundation
 
Carla Isadora Falkson
Honoraria - Curio Science
Consulting or Advisory Role - Agendia; bioTheranostics
Speakers' Bureau - OncLive/MJH Life Sciences
Research Funding - Lilly (Inst); Oncolytics (Inst); QuantumLeap Health (Inst)
 
Kathy S. Albain
Honoraria - Encore Medical Education
Research Funding - Quantum Leap Healthcare Collaborative (Inst); Seagen (Inst)
Other Relationship - Seagen
 
Ingrid A. Mayer
Employment - AstraZeneca
Leadership - AstraZeneca
Consulting or Advisory Role - Abbvie; AstraZeneca; Blueprint Medicines; Cyclacel; Genentech; GlaxoSmithKline; Immunomedics; Lilly; Macrogenics; Novartis; Pfizer; Puma Biotechnology; Sanofi; Seagen
Research Funding - Genentech (Inst); Novartis (Inst); Pfizer (Inst)
 
Meghna S. Trivedi
Research Funding - AstraZeneca (Inst); Gilead Sciences (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Phoenix Molecular Designs (Inst); Regeneron (Inst)
 
Rita Nanda
Consulting or Advisory Role - AstraZeneca; BeyondSpring Pharmaceuticals; Cardinal Health; Fujifilm; GE Healthcare; Gilead Sciences; Infinity Pharmaceuticals; ITeos Therapeutics; Merck; OBI Pharma; OncoSec; Sanofi; Seagen
Research Funding - Arvinas (Inst); AstraZeneca (Inst); Celgene (Inst); Corcept Therapeutics (Inst); Genentech/Roche (Inst); Immunomedics (Inst); Merck (Inst); OBI Pharma (Inst); Odonate Therapeutics (Inst); OncoSec (Inst); Pfizer (Inst); Relay Therapeutics (Inst); Seagen (Inst); Sun Pharma (Inst); Taiho Oncology (Inst)
Other Relationship - G1 Therapeutics
 
Emily H. Douglas
No Relationships to Disclose
 
Coral Oghenerukevwe Omene
No Relationships to Disclose
 
Hope S. Rugo
Consulting or Advisory Role - Blueprint Medicines; Napo Pharmaceuticals; Puma Biotechnology; Scorpion Therapeutics
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Daiichi Sankyo (Inst); Genentech (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); OBI Pharma (Inst); Pfizer (Inst); Pionyr (Inst); Sermonix Pharmaceuticals (Inst); Taiho Oncology (Inst); Veru (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Gilead Sciences; Merck
 
Claudine Isaacs
Consulting or Advisory Role - AstraZeneca/MedImmune; bioTheranostics; Genentech/Roche; Gilead Sciences; Ion Solutions; Novartis; Pfizer; Puma Biotechnology; Seagen
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb/Celgene (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Seagen (Inst); Tesaro (Inst)
Patents, Royalties, Other Intellectual Property - Elsevier - Editor of Book; McGraw Hill Publishing; UpToDate - Wolters Kluwer - Author of chapters
Other Relationship - Side-Out Foundation
 
Beverly Parker
No Relationships to Disclose
 
Angela DeMichele
Consulting or Advisory Role - Pfizer (I)
Research Funding - Calithera Biosciences (Inst); Genentech (Inst); Inivata/NeoGenomics (Inst); Novartis (Inst); Pfizer (Inst)
 
Douglas Yee
Honoraria - Boehringer Ingelheim
Consulting or Advisory Role - Martell diagnostic
Research Funding - Boehringer Ingelheim
 
Laura Esserman
Consulting or Advisory Role - Blue Cross Blue Shield Association
Research Funding - Merck
Travel, Accommodations, Expenses - Blue Cross Blue Shield Association
(OPTIONAL) Uncompensated Relationships - Quantum Leap Healthcare Collaborative